Geratherm Medical AG (XTER:GME) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG ROE % Adjusted to Book Value?

Geratherm Medical AG's ROE % for the quarter that ended in Jun. 2023 was 0.00%. Geratherm Medical AG's PB Ratio for the quarter that ended in Jun. 2023 was 1.72. Geratherm Medical AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was 0.00%.

Geratherm Medical AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Geratherm Medical AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geratherm Medical AG ROE % Adjusted to Book Value Chart

Geratherm Medical AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

2.07

1.30

3.83

0.28

4.16

Geratherm Medical AG Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															5.10	2.59	2.48	1.94	-

Competitive Comparison of Geratherm Medical AG's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Geratherm Medical AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Geratherm Medical AG's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's ROE % Adjusted to Book Value falls into.

Geratherm Medical AG ROE % Adjusted to Book Value Calculation

Geratherm Medical AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.07%	/	1.22
	=	4.16%

Geratherm Medical AG's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	1.72
	=	0.00%

Geratherm Medical AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Geratherm Medical AG (XTER:GME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

GME:Germany

Address

Fahrenheitstrasse 1, Geratal, DEU, 99331

Website

https://www.geratherm.com

Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

Executives